Charlotte Lässig

1.1k total citations · 1 hit paper
9 papers, 859 citations indexed

About

Charlotte Lässig is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Charlotte Lässig has authored 9 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Charlotte Lässig's work include interferon and immune responses (6 papers), RNA regulation and disease (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Charlotte Lässig is often cited by papers focused on interferon and immune responses (6 papers), RNA regulation and disease (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Charlotte Lässig collaborates with scholars based in Germany, United States and Czechia. Charlotte Lässig's co-authors include Karl‐Peter Hopfner, Veit Hornung, Carina C. de Oliveira Mann, Konstantin M. J. Sparrer, Björn Hiller, Andreas Maiser, Dirk Kostrewa, Heinrich Leonhardt, Liudmila Andreeva and Moritz M. Gaidt and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Charlotte Lässig

9 papers receiving 855 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein–DNA ladders

2017 395 citations Liudmila Andreeva, Björn Hiller et al. Nature profile →

Peers

Countries citing papers authored by Charlotte Lässig

Since Specialization

Citations

This map shows the geographic impact of Charlotte Lässig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Lässig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Lässig more than expected).

Fields of papers citing papers by Charlotte Lässig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Lässig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Lässig. The network helps show where Charlotte Lässig may publish in the future.

Co-authorship network of co-authors of Charlotte Lässig

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Lässig. A scholar is included among the top collaborators of Charlotte Lässig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Lässig. Charlotte Lässig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma 2022 ·Clinical Lymphoma Myeloma & Leukemia ·David Belada, Kateřina Kopečková, (unknown), Don A. Stevens, Grzegorz S. Nowakowski, Maeve Waldron-Lynch, Nira Hadar, Johannes Weirather, Charlotte Lässig, Derek Blair, Martin Dreyling	1
2	Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL). 2022 ·Journal of Clinical Oncology ·David Belada, Kateřina Kopečková, (unknown), Don A. Stevens, Grzegorz S. Nowakowski, (unknown), Nira Hadar, Johannes Weirather, Charlotte Lässig, Derek Blair, Martin Dreyling	1
3	Unified mechanisms for self-RNA recognition by RIG-I Singleton-Merten syndrome variants 2018 ·eLife ·Charlotte Lässig, Katja Lammens, (unknown), (unknown), (unknown), Karl‐Peter Hopfner	28
4	Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors 2017 ·Journal of Biological Chemistry ·Charlotte Lässig, Karl‐Peter Hopfner	59
5	cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein–DNA ladders breakdown → 2017 ·Nature ·Liudmila Andreeva, Björn Hiller, Dirk Kostrewa, Charlotte Lässig, Carina C. de Oliveira Mann, David Drexler, Andreas Maiser, Moritz M. Gaidt, Heinrich Leonhardt, Veit Hornung, Karl‐Peter Hopfner	395
6	Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity 2017 ·Nature Immunology ·Jessica J. Chiang, Konstantin M. J. Sparrer, Michiel van Gent, Charlotte Lässig, Teng Huang, Nikolaus Osterrieder, Karl‐Peter Hopfner, Michaela U. Gack	188
7	ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA 2015 ·eLife ·Charlotte Lässig, (unknown), Konstantin M. J. Sparrer, Carina C. de Oliveira Mann, Manuela Moldt, Jenish Patel, Marion Goldeck, Gunther Hartmann, Adolfo Garcı́a-Sastre, Veit Hornung, Karl‐Klaus Conzelmann, Roland Beckmann, Karl‐Peter Hopfner	78
8	In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells 2014 ·PLoS Pathogens ·(unknown), Konstantin M. J. Sparrer, Charlotte Lässig, Katharina Hembach, Alina Baum, Adolfo Garcı́a-Sastre, Johannes Söding, Karl‐Klaus Conzelmann, Karl‐Peter Hopfner	107
9	Transcriptional control of lipid metabolism by the MarR ‐like regulator FamR and the global regulator GlxR in the lipophilic axilla isolate C orynebacterium jeikeium K 411 2012 ·Microbial Biotechnology ·(unknown), (unknown), Charlotte Lässig, Iris Brune, Andreas Tauch	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact